JPS60130520A - 脳卒中予防・治療剤 - Google Patents

脳卒中予防・治療剤

Info

Publication number
JPS60130520A
JPS60130520A JP23602083A JP23602083A JPS60130520A JP S60130520 A JPS60130520 A JP S60130520A JP 23602083 A JP23602083 A JP 23602083A JP 23602083 A JP23602083 A JP 23602083A JP S60130520 A JPS60130520 A JP S60130520A
Authority
JP
Japan
Prior art keywords
cerebral
drug
stroke
infarction
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP23602083A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0369324B2 (enExample
Inventor
Kazunaga Fukawa
府川　和永
Kazuyoshi Bando
坂東　和良
Keiichi Hatanaka
畑中　佳一
Kikuo Nakazato
中里　紀久男
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aska Pharmaceutical Co Ltd
Original Assignee
Grelan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grelan Pharmaceutical Co Ltd filed Critical Grelan Pharmaceutical Co Ltd
Priority to JP23602083A priority Critical patent/JPS60130520A/ja
Priority to EP84100760A priority patent/EP0115331B1/en
Priority to DE19843402058 priority patent/DE3402058A1/de
Priority to DE8484100760T priority patent/DE3461891D1/de
Priority to CA000445863A priority patent/CA1229793A/en
Priority to IT8467076A priority patent/IT1214838B/it
Priority to US06/749,444 priority patent/US4652581A/en
Publication of JPS60130520A publication Critical patent/JPS60130520A/ja
Publication of JPH0369324B2 publication Critical patent/JPH0369324B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
JP23602083A 1983-01-24 1983-12-16 脳卒中予防・治療剤 Granted JPS60130520A (ja)

Priority Applications (7)

Application Number Priority Date Filing Date Title
JP23602083A JPS60130520A (ja) 1983-12-16 1983-12-16 脳卒中予防・治療剤
EP84100760A EP0115331B1 (en) 1983-01-24 1984-01-21 Medicament for cerebral apoplexy
DE19843402058 DE3402058A1 (de) 1983-01-24 1984-01-21 Medikament gegen cerebrale apoplexie
DE8484100760T DE3461891D1 (de) 1983-01-24 1984-01-21 Medicament for cerebral apoplexy
CA000445863A CA1229793A (en) 1983-01-24 1984-01-23 Medicament for cerebral apoplexy
IT8467076A IT1214838B (it) 1983-01-24 1984-01-24 Farmaco per la terapia dell apoplessia cerebrale e composizione farmaceutica che lo contiene
US06/749,444 US4652581A (en) 1983-01-24 1985-06-27 Tetrahydroindole derivative as medicament for cerebral apoplexy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23602083A JPS60130520A (ja) 1983-12-16 1983-12-16 脳卒中予防・治療剤

Publications (2)

Publication Number Publication Date
JPS60130520A true JPS60130520A (ja) 1985-07-12
JPH0369324B2 JPH0369324B2 (enExample) 1991-10-31

Family

ID=16994575

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23602083A Granted JPS60130520A (ja) 1983-01-24 1983-12-16 脳卒中予防・治療剤

Country Status (1)

Country Link
JP (1) JPS60130520A (enExample)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
J.PHARM.SCI=1967 *

Also Published As

Publication number Publication date
JPH0369324B2 (enExample) 1991-10-31

Similar Documents

Publication Publication Date Title
TW518222B (en) Pharmaceutical composition comprising a combination of metformin and fibrate, and its use for the preparation of medicines intended to reduce hyperglycaemia
EP0349235A2 (en) Niacin and guar-gum containing composition
AU635533B2 (en) Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions
JP5684954B1 (ja) 安定性を改善したロクロニウム製剤
US4210670A (en) Antithrombotic agents
JP2008525504A (ja) 関節痛を治療する薬剤を生成するためのレシニフェラトキシン（ｒｔｘ）の使用方法および前記薬剤を適用する方法
NZ787785A (en) Delayed release deferiprone tablets and methods of using the same
WO2021181159A1 (en) Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy
DE10139410A1 (de) Verwendung von BIBN4096 in Kombination mit anderen Arzneistoffen gegen Migräne für die Behandlung von Migräne
DE60301862T2 (de) Kombinationsbehandlung bei akutem myokardinfarkt
JP2025011312A (ja) ｐ－ボロノフェニルアラニンを含有する注射液剤の析出防止方法
JPS60130520A (ja) 脳卒中予防・治療剤
RU2425669C1 (ru) Средство для профилактики и лечения острого и хронического панкреатита
JP2012158603A (ja) 耐糖能異常用医薬組成物及び飲食品
EP2184284B1 (en) Preventive, inhibitor or remedy for cerebral aneurysm comprising ibudilast as an active ingredient
Sandercock Antiplatelet therapy with aspirin in acute ischaemic stroke
US4517309A (en) Method for the treatment of calcifying pancreatitis
JPS59134722A (ja) 出血性梗塞予防・治療剤
US12502371B2 (en) Drug for treating and preventing dementia
JP7498475B2 (ja) 多発性骨髄腫の治療剤
Afolayan et al. Reversal of spinal anaesthesia and prevention of post operative complications using intralipid emulsion
Loreto et al. 4CPS-223 Efficacy and safety of darolutamide in the routine clinical practice conditions
JPH09227381A (ja) 脳血栓における運動麻痺の改善剤
JP2026501344A (ja) 新規な溶液
TWI794847B (zh) 用於減少代謝症候群之組合物及其應用